ERBB2 and breast carcinoma: We screened the first five pathways of the two types of breast cancer according to P value, in which purine metabolism, tyrosine metabolism, metabolism of xenobiotics by cytochrome P450, and drug metabolism were the main enrichment pathways of differential metabolic genes in HER2-positive breast cancer.